KCNA5 and Hypertension: Our conclusions substantiate the work of other groups, namely that patients with genetic mutations of KCNA5 exhibit pulmonary arterial hypertension and arterial fibrillation but not systemic hypertension (Yang et al., 2009; Wipff et al., 2010; Machado et al., 2015).